Pre-treatment with GLP significantly attenuated acute pneumonia by inhibiting inflammatory cell infiltration, reducing cytokine secretion, downregulating NRP1 expression and suppressing pneumonocyte apoptosis and autophagy. Here, NRP1 is linked to susceptibility to pneumonia measurement.